| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 95 | 340 | 1,010 | $100 | $511K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 211 | 260 | 860 | $80 | $222.6K |
| 99212 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,… | 80 | 160 | 210 | $120 | $97.4K |
| 90471 | In this procedure, the provider administers a live attenuated vaccine using a percutaneous, intradermal, subcutaneous, or intramuscular route. | 115 | 160 | 180 | $40 | $59.6K |
| W0037 | N/A | 93 | 160 | 690 | $20 | $50.1K |
| 99394 | The provider performs an established well–patient visit for an adolescent who is between the ages of 12 and 17. | 60 | 70 | 110 | $110 | $42.9K |
| 87880 | The analyst performs an immunoassay with direct optical, meaning visual, observation to detect Streptococcus, group A, in a patient sample, typically a throat swab. | 53 | 80 | 210 | $30 | $18K |
| 87804 | The analyst performs an immunoassay with direct optical, meaning visual, observation to detect influenza, also called flu, in a patient sample, typically a throat or nasal swab or nasal washings. | 39 | 70 | 210 | $20 | $14.7K |
| 87426 | The lab analyst performs an immunoassay to qualitatively or semiquantitatively evaluate the patient blood specimen for antigens of severe acute respiratory syndrome coronavirus such as SARS–CoV–2,… | 16 | 40 | 50 | $30 | $14.1K |
| 90686 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is preservative free, uses split virus technology, and is given as a 0.5 mL… | 113 | 130 | 110 | $10 | $6.9K |